Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
March 20, 2026 16:30 ET | Source: Zevra Therapeutics BOSTON, March 20,…
InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX),…
Eightco (NASDAQ: ORBS) Secures $125M in Institutional Commitments Led by Bitmine (NYSE: BMNR), Cathie Wood’s ARK Invest, and Payward to Expand into Next Generation Technology
ORBS makes strategic investments in category-defining companies, including OpenAI and Beast IndustriesTom…
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:…
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2026 17:33 ET | Source: Tango Therapeutics Sub, Inc BOSTON,…
Orangekloud Technology Inc. Regains Compliance with Nasdaq Listing Requirements
Singapore, March 03, 2026 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (NASDAQ: ORKT)…
TheSportExchange Announces Intent to Pursue NASDAQ Direct Listing
Performance-linked digital asset marketplace targeting H2 2026 listing; public launch scheduled for…
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB),…
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:…
HCW Biologics Announces Pricing of $1.5 Million Follow-On OfferingPriced At-The-Market Under NASDAQ Rules
MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the…
